StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.25−0.14 (-10.07%)

Close on Nov 20, 2026Market cap $46.78MP/E –Yield –

Tenax Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Tenax Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0. The highest annual figure on record is $1.19M in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0-100.0%
FY2015Apr 30, 2015$49.29K-69.0%
FY2014Apr 30, 2014$158.93K-86.7%
FY2013Apr 30, 2013$1.19M+227.4%
FY2012Apr 30, 2012$363.78K+252.6%
FY2011Apr 30, 2011$103.17K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$0–
Q1 FY2026CQ1 2026Mar 31, 2026$0–
Q4 FY2025CQ4 2025Dec 31, 2025$0-100.0%
Q3 FY2025CQ3 2025Sep 30, 2025$0–
Q2 FY2025CQ2 2025Jun 30, 2025$0–
Q1 FY2025CQ1 2025Mar 31, 2025$0–
Q4 FY2015CQ1 2015Apr 30, 2015$49.29K–
Q3 FY2015CQ4 2014Jan 31, 2015$0–

More Tenax Therapeutics figures

See a number that looks wrong?